Montelukast Prescribing at GATEWAY PRIMARY CARE
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,281
Total Quantity
33.6K
NHS Cost
£1.9K
vs National Avg
+87.1%
GATEWAY PRIMARY CARE prescribed 1,281 items of Montelukast over the last 12 months at a cost of £1,871 to the NHS. This is 87.1% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
106
Jun 2026
103
Jun 2026
103
Jun 2026
107
Jun 2026
106
Jun 2026
95
Jun 2026
107
Jun 2026
109
Jun 2026
109
Jun 2026
102
Jun 2026
113
Jun 2026
121
Prescribing Details
| Total Items | 1,281 |
|---|---|
| Total Quantity | 33,628 |
| Total NHS Cost | £1,871 |
| Presentations | 5 different forms |
| vs National Average | +87.1% |
Montelukast Prescribing Comparison
| This practice | 1,281 items |
|---|---|
| National average per practice | 685 items |
| Difference | +87.1% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.